Calidi Biotherapeutics Inc (CLDI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2017 | |
| Sales | 0 | 0 | 45 | 0 | 0 |
| Cost of Goods | N/A | N/A | 14 | N/A | N/A |
| Gross Profit | N/A | N/A | 31 | N/A | N/A |
| Operating Expenses | 21,776 | 28,992 | 23,173 | 1,782 | 0 |
| Operating Income | -21,776 | -28,992 | -23,128 | -1,782 | N/A |
| Interest Expense | 933 | 1,069 | 158 | 0 | 0 |
| Other Income | 514 | 861 | -2,130 | 5,169 | 0 |
| Pre-tax Income | -22,195 | -29,200 | -25,416 | 3,387 | 0 |
| Income Tax | 14 | 16 | 11 | N/A | N/A |
| Net Income Continuous | -22,209 | -29,216 | -25,427 | 3,387 | N/A |
| Minority Interests | -66 | N/A | N/A | N/A | N/A |
| Net Income | $-22,143 | $-29,216 | $-25,427 | $3,387 | $N/A |
| EPS Basic Total Ops | -35.65 | -208.04 | -358.94 | -120.05 | N/A |
| EPS Basic Continuous Ops | -33.31 | -208.03 | -358.90 | 70.71 | N/A |
| EPS Diluted Total Ops | -35.65 | -208.04 | -358.94 | -120.05 | N/A |
| EPS Diluted Continuous Ops | -33.31 | -208.03 | -358.90 | 70.71 | N/A |
| EPS Diluted Before Non-Recurring Items | -35.65 | -207.68 | N/A | N/A | N/A |
| EBITDA(a) | $-20,196 | $-27,304 | $-22,752 | $-1,782 | $N/A |